Patents by Inventor Dan ARDOUREL

Dan ARDOUREL has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CD80 VARIANT IMMUNOMODULATORY PROTEINS AND USES THEREOF
    Publication number: 20240002466
    Abstract: Provided herein are variant CD80 polypeptides, immunomodulatory proteins comprising variant CD80 polypeptides, and nucleic acids encoding such proteins. The immunomodulatory proteins provide therapeutic utility for a variety of immunological and oncological conditions. Compositions and methods for making and using such proteins are provided.
    Type: Application
    Filed: March 10, 2023
    Publication date: January 4, 2024
    Applicant: Alpine Immune Sciences, Inc.
    Inventors: Ryan Swanson, Michael Kornacker, Mark F. Maurer, Dan Ardourel, Daniel William Demonte, Joseph L. Kuijper
  • CD112 variant immunomodulatory proteins and uses thereof
    Patent number: 11834490
    Abstract: Provided herein are immunomodulatory proteins comprising variant CD112 and nucleic acids encoding such proteins. The immunomodulatory proteins provide therapeutic utility for a variety of immunological and oncological conditions. Compositions and methods for making and using such proteins are provided.
    Type: Grant
    Filed: July 27, 2017
    Date of Patent: December 5, 2023
    Assignee: ALPINE IMMUNE SCIENCES, INC.
    Inventors: Ryan Swanson, Michael Kornacker, Daniel William Demonte, Mark F. Maurer, Dan Ardourel, Joseph L. Kuijper
  • PD-L2 variant immunomodulatory proteins and uses thereof
    Patent number: 11732022
    Abstract: Provided herein are immunomodulatory proteins comprising variant PD-L2 and nucleic acids encoding such proteins. The immunomodulatory proteins provide therapeutic utility for a variety of immunological and oncological conditions. Compositions and methods for making and using such proteins are provided.
    Type: Grant
    Filed: March 13, 2018
    Date of Patent: August 22, 2023
    Assignee: Alpine Immune Sciences, Inc.
    Inventors: Ryan Swanson, Michael Kornacker, Mark F. Maurer, Dan Ardourel, Daniel William Demonte, Joseph L. Kuijper
  • PD-L1 VARIANT IMMUNOMODULATORY PROTEINS AND USES THEREOF
    Publication number: 20230220039
    Abstract: Provided herein are immunomodulatory proteins comprising variant PD-L1 and nucleic acids encoding such proteins. The immunomodulatory proteins provide therapeutic utility for a variety of immunological and oncological conditions. Compositions and methods for making and using such proteins are provided.
    Type: Application
    Filed: March 13, 2018
    Publication date: July 13, 2023
    Applicant: Alpine Immune Sciences, Inc.
    Inventors: Ryan SWANSON, Michael KORNACKER, Mark F. MAURER, Dan ARDOUREL, Daniel William DEMONTE, Joseph L. KUJIPER
  • CD86 VARIANT IMMUNOMODULATORY PROTEINS AND USES THEREOF
    Publication number: 20220372106
    Abstract: Provided herein are variant CD86 polypeptides, immunomodulatory proteins comprising variant CD86 polypeptides, and nucleic acids encoding such proteins. The immunomodulatory proteins provide therapeutic utility for a variety of immunological and oncological conditions. Compositions and methods for making and using such proteins are provided.
    Type: Application
    Filed: November 27, 2019
    Publication date: November 24, 2022
    Applicant: Alpine Immune Sciences, Inc.
    Inventors: Ryan SWANSON, Dan ARDOUREL, Steven Dennis LEVIN, Joseph L. KUIJPER
  • CD112 VARIANT IMMUNOMODULATORY PROTEINS AND USES THEREOF
    Publication number: 20210253668
    Abstract: Provided herein are immunomodulatory proteins comprising variant CD112 and nucleic acids encoding such proteins. The immunomodulatory proteins provide therapeutic utility for a variety of immunological and oncological conditions. Compositions and methods for making and using such proteins are provided.
    Type: Application
    Filed: July 27, 2017
    Publication date: August 19, 2021
    Applicant: ALPINE IMMUNE SCIENCES, INC.
    Inventors: Ryan SWANSON, Michael KORNACKER, Daniel William DEMONTE, Mark F. MAURER, Dan ARDOUREL, Joseph L. KUIJPER
  • CD80 VARIANT IMMUNOMODULATORY PROTEINS AND USES THEREOF
    Publication number: 20210188942
    Abstract: Provided herein are variant CD80 polypeptides, immunomodulatory proteins comprising variant CD80 polypeptides, and nucleic acids encoding such proteins. The immunomodulatory proteins provide therapeutic utility for a variety of immunological and oncological conditions. Compositions and methods for making and using such proteins are provided.
    Type: Application
    Filed: January 29, 2021
    Publication date: June 24, 2021
    Applicant: Alpine Immune Sciences, Inc.
    Inventors: Ryan SWANSON, Michael KORNACKER, Mark F. MAURER, Dan ARDOUREL, Daniel William DEMONTE, Joseph L. KUIJPER
  • CD80 VARIANT IMMUNOMODULATORY PROTEINS AND USES THEREOF
    Publication number: 20210171603
    Abstract: Provided herein are variant CD80 polypeptides, immunomodulatory proteins comprising variant CD80 polypeptides, and nucleic acids encoding such proteins. The immunomodulatory proteins provide therapeutic utility for a variety of immunological and oncological conditions. Compositions and methods for making and using such proteins are provided.
    Type: Application
    Filed: January 29, 2021
    Publication date: June 10, 2021
    Applicant: Alpine Immune Sciences, Inc.
    Inventors: Ryan SWANSON, Michael KORNACKER, Mark F. MAURER, Dan ARDOUREL, Daniel William DEMONTE, Joseph L. KUIJPER
  • CD80 VARIANT IMMUNOMODULATORY PROTEINS AND USES THEREOF
    Publication number: 20210163571
    Abstract: Provided herein are variant CD80 polypeptides, immunomodulatory proteins comprising variant CD80 polypeptides, and nucleic acids encoding such proteins. The immunomodulatory proteins provide therapeutic utility for a variety of immunological and oncological conditions. Compositions and methods for making and using such proteins are provided.
    Type: Application
    Filed: January 28, 2021
    Publication date: June 3, 2021
    Applicant: Alpine Immune Sciences, Inc.
    Inventors: Ryan SWANSON, Michael KORNACKER, Mark F. MAURER, Dan ARDOUREL, Daniel William DEMONTE, Joseph L. KUIJPER
  • CD80 VARIANT IMMUNOMODULATORY PROTEINS AND USES THEREOF
    Publication number: 20210155668
    Abstract: Provided herein are variant CD80 polypeptides, immunomodulatory proteins comprising variant CD80 polypeptides, and nucleic acids encoding such proteins. The immunomodulatory proteins provide therapeutic utility for a variety of immunological and oncological conditions. Compositions and methods for making and using such proteins are provided.
    Type: Application
    Filed: January 28, 2021
    Publication date: May 27, 2021
    Applicant: Alpine Immune Sciences, Inc.
    Inventors: Ryan SWANSON, Michael KORNACKER, Mark F. MAURER, Dan ARDOUREL, Daniel William DEMONTE, Joseph L. KUIJPER
  • CD80 VARIANT IMMUNOMODULATORY PROTEINS AND USES THEREOF
    Publication number: 20210155669
    Abstract: Provided herein are variant CD80 polypeptides, immunomodulatory proteins comprising variant CD80 polypeptides, and nucleic acids encoding such proteins. The immunomodulatory proteins provide therapeutic utility for a variety of immunological and oncological conditions. Compositions and methods for making and using such proteins are provided.
    Type: Application
    Filed: January 28, 2021
    Publication date: May 27, 2021
    Applicant: Alpine Immune Sciences, Inc.
    Inventors: Ryan SWANSON, Michael KORNACKER, Mark F. MAURER, Dan ARDOUREL, Daniel William DEMONTE, Joseph L. KUIJPER
  • CD80 VARIANT IMMUNOMODULATORY PROTEINS AND USES THEREOF
    Publication number: 20210130436
    Abstract: Provided herein are variant CD80 polypeptides, immunomodulatory proteins comprising variant CD80 polypeptides, and nucleic acids encoding such proteins. The immunomodulatory proteins provide therapeutic utility for a variety of immunological and oncological conditions. Compositions and methods for making and using such proteins are provided.
    Type: Application
    Filed: March 13, 2018
    Publication date: May 6, 2021
    Applicant: Alpine Immune Sciences, Inc.
    Inventors: Ryan SWANSON, Michael KORNACKER, Mark F. MAURER, Dan ARDOUREL, Daniel William DEMONTE, Joseph L. KUIJPER
  • PD-L2 VARIANT IMMUNOMODULATORY PROTEINS AND USES THEREOF
    Publication number: 20210130437
    Abstract: Provided herein are immunomodulatory proteins comprising variant PD-L2 and nucleic acids encoding such proteins. The immunomodulatory proteins provide therapeutic utility for a variety of immunological and oncological conditions. Compositions and methods for making and using such proteins are provided.
    Type: Application
    Filed: March 13, 2018
    Publication date: May 6, 2021
    Applicant: Alpine Immune Sciences, Inc.
    Inventors: Ryan SWANSON, Michael KORNACKER, Mark F. MAURER, Dan ARDOUREL, Daniel William DEMONTE, Joseph L. KUIJPER
  • CD155 VARIANT IMMUNOMODULATORY PROTEINS AND USES THEREOF
    Publication number: 20190175654
    Abstract: Provided herein are immunomodulatory proteins comprising variant CD155 and nucleic acids encoding such proteins. The immunomodulatory proteins provide therapeutic utility for a variety of immunological and oncological conditions. Compositions and methods for making and using such proteins are provided.
    Type: Application
    Filed: July 27, 2017
    Publication date: June 13, 2019
    Applicant: ALPINE IMMUNE SCIENCES, INC.
    Inventors: Ryan SWANSON, Michael KORNACKER, Daniel William DEMONTE, Mark F. MAURER, Dan ARDOUREL, Joseph L. KUIJPER